Reducing Total Cardiovascular Risk in an Urban Community
Summary
PLEASE NOTE: THIS STUDY IS ONLY ENROLLING PATIENTS CURRENTLY BEING TREATED AT BELAIR-EDISON FAMILY HEALTH CENTER. The purpose of this study is to compare the clinical effectiveness and cost effectiveness of two cardiovascular risk reduction programs - a comprehensive intensive (Cl) intervention with a less intensive (LI) intervention - in African American, and white low-income patients with known excessive cardiovascular disease risk.
Timeline
- Start
- 2006-05
- Primary completion
- 2010-05
- Completion
- 2010-05
Outcome
Mixed primary results
registry MEAN Comprehensive Intervention Group: 100.1 (Standard Deviation 39.2) mg/dL NCT00241904 ↗
registry MEAN Less Intensive Intervention Group: 110.6 (Standard Deviation 36.8) mg/dL NCT00241904 ↗
registry analysis (superiority test); Comprehensive Intervention Group vs Less Intensive Intervention Group; p <0.001; General Linear Mixed Model NCT00241904 ↗
registry MEAN Comprehensive Intervention Group: 130.8 (Standard Deviation 20.7) mmHg NCT00241904 ↗
registry MEAN Less Intensive Intervention Group: 135.9 (Standard Deviation 20.5) mmHg NCT00241904 ↗
registry analysis (superiority test); Comprehensive Intervention Group vs Less Intensive Intervention Group; p = 0.003; General Linear Mixed Model NCT00241904 ↗
registry MEAN Comprehensive Intervention Group: 8.3 (Standard Deviation 2.2) percentage of hemoglobin NCT00241904 ↗
registry MEAN Less Intensive Intervention Group: 8.2 (Standard Deviation 2.1) percentage of hemoglobin NCT00241904 ↗
registry analysis (superiority test); Comprehensive Intervention Group vs Less Intensive Intervention Group; p = 0.034; General Linear Mixed Model NCT00241904 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ACE Inhibitors | Unknown | — | Oral |
| Subject | Aspirin | Small molecule | 81 mg | — |
| Subject | Atenolol | Other / unclassified | — | Oral |
| Subject | Metoprolol | Other / unclassified | — | Oral |
| Subject | Propranolol | Small molecule | — | Oral |